EFFECTS OF TREATMENT AND OF WITHDRAWAL OF TREATMENT WITH GUANFACINE AND CLONIDINE ON BLOOD-PRESSURE AND HEART-RATE IN NORMOTENSIVE AND RENAL HYPERTENSIVE RATS

被引:25
作者
SALZMANN, R
机构
[1] Medical and Biological Research Department, Sandoz Ltd., Basle
关键词
D O I
10.1111/j.2042-7158.1979.tb13481.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Disagreement in the literature about the occurrence of rebound hypertension (hypertensive overshoot) in animal models initiated this investigation. Oral doses of clonidine (0.03 mg kg−1) or guanfacine (0.3 mg kg−1) were administered twice daily during three weeks to groups of normotensive and renal hypertensive rats. Blood pressure and heart rate were measured immediately before and 3 h after the first daily dose, and compared with values obtained from placebo‐treated control rats. Treatment with either drug induced large daily fluctuations rather than sustained falls in blood pressure. In the normotensive, but not in the hypertensive groups, the morning blood pressures measured before the first daily dose were significantly elevated over those of the control groups after 9 and 5 days of treatment with clonidine or guanfacine. This elevation persisted for 3 days after drug withdrawal. It is concluded that in the rat the duration of action of both drugs was short, so that twice daily administration of both drugs similarly produced large daily fluctuations rather than sustained falls in blood pressure. Blood pressure rises developed during treatment rather than after withdrawal in normotensive rats only. Therefore, this type of study does not relate well to the human situation and different experimental approaches to this problem are needed. 1979 Royal Pharmaceutical Society of Great Britain
引用
收藏
页码:212 / 216
页数:5
相关论文
共 15 条
[1]  
Cavero I, 1977, Br J Pharmacol, V60, p288P
[2]   WITHDRAWAL SYNDROME UPON CESSATION OF CHRONIC CLONIDINE TREATMENT IN RATS [J].
DIX, RK ;
JOHNSON, EM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 44 (02) :153-159
[3]  
FRIEDMAN M, 1949, P SOC EXP BIOL MED, V70, P670
[4]  
GEDDES LA, 1970, DIRECT INDIRECT MEAS, P138
[5]  
Grollman A, 1944, P SOC EXP BIOL MED, V57, P102
[6]   BLOOD-PRESSURE CRISIS FOLLOWING WITHDRAWAL OF CLONIDINE (CATAPRES, CATAPRESAN), WITH SPECIAL REFERENCE TO ARTERIAL AND URINARY CATECHOLAMINE LEVELS, AND SUGGESTIONS FOR ACUTE MANAGEMENT [J].
HANSSON, L ;
HUNYOR, SN ;
JULIUS, S ;
HOOBLER, SW .
AMERICAN HEART JOURNAL, 1973, 85 (05) :605-610
[7]   STUDIES ON CATECHOLAMINES, RENIN AND ALDOSTERONE FOLLOWING CATAPRESAN (2-(2,6-DICHLOR-PHENYLAMINE)-2-IMIDAZOLINE HYDROCHLORIDE) IN HYPERTENSIVE PATIENTS [J].
HOKFELT, B ;
HEDELAND, H ;
DYMLING, JF .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 10 (03) :389-+
[8]  
HOLLANDER M, 1973, NONPARAMETRIC STAT M, P130
[9]   COMPARISON OF BS 100-141 AND CLONIDINE AS ANTIHYPERTENSIVE AGENTS [J].
JAATTELA, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 10 (01) :73-76
[10]  
KIRCH W, 1978, INT J CLIN PHARM BI, V16, P132